Astellas Pharma Inc: Renal Insufficiency trials

The registry lists 18 Renal Insufficiency studies with Astellas Pharma Inc as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 10Phase 3 5Phase 4 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal ImpairmentCompletedNCT00863707Phase 4Results posted
• A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work WellCompletedNCT05495581Phase 1
• A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy PeopleCompletedNCT05117294Phase 1
• A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal FunctionCompletedNCT04476849Phase 1
• A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal FunctionCompletedNCT02965040Phase 1
• ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and HaemodialysisCompletedNCT02629224Phase 1
• Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal FunctionCompletedNCT02603497Phase 1
• Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal DialysisCompletedNCT01903213
• Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742611Phase 3
• A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742585Phase 3
• Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.CompletedNCT01555866Phase 1
• Renal Impairment Study With ASP1941CompletedNCT01302028Phase 1
• ASP1517 Pharmacokinetics Study in Anemia Patients on HemodialysisCompletedNCT01083888Phase 1
• A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT01057407Phase 3
• A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal DialysisCompletedNCT01017276Phase 3
• Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on HemodialysisCompletedNCT00892749Phase 3
• A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal ImpairmentCompletedNCT00750620Phase 1
• Study of Tacrolimus Immunosuppressive Therapy After Kidney TransplantationCompletedNCT00717379Phase 4